The findings from the KEGG analysis demonstrate that PRPF19 has a regulatory role in several aspects of bladder cancer cell biology, including senescence, cell cycle progression, and resistance to platinum-based drugs (Figures 3E, F). This evidence concerns the gene PRPF19 and urinary bladder carcinoma.